RankAlpha logo
Back to Rankings

CMMB

Chemomab TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
CMMB vs peer average
45/100
CMMB vs. peer average (F vs. F)
Grade spread
D 3 · F 7
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

AKTX is the first available peer comparator.

Same-sector microcap benchmark; the packet provides no direct PSC or nebokitug read-through, so comparison is mainly volatility and financing risk.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAKTXAkari Therapeutics
CMMB
Chemomab Therapeutics
AKTX
Akari Therapeutics
Grade
F
F
Momentum
84
40
Value
41
42
Sentiment
10
17
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs AKTX

CMMB / AKTX
Grade Position
In line
CMMB vs. peer average (F vs. F)
45/100
Momentum
84
CMMB
Value
41
AKTX
Sentiment
10
AKTX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CMMB
1
AKTX
AKTX
F
20/100
Even
2
BIVI
BIVI
F
20/100
Even
3
CRIS
CRIS
D
40/100
-1
4
PBM
Psyence Biomedical Ltd Common
F
20/100
Even
5
BNGO
Bionano Genomics Inc Common
F
20/100
Even
AKTX is the first peer returned for this comparison set.